GLP-1 receptor agonists should not be co-prescribed with DPP-4 inhibitors, as this combination is not recommended in UK practice
They meet modern clinical standards for a viable pregnancy without needing a full 100 percent double
It also improves insulin sensitivity but does not affect insulin secretion from the pancreas
placebo showing superiority in incidence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke
Once reconstituted with bacteriostatic water, the solution requires continuous refrigeration at 2-8 degrees Celsius
Medications like Semaglutide (Wegovy, Ozempic) or Tirzepatide (Mounjaro, Zepbound) activate GLP-1 receptors to: Delay stomach emptying Reduce hunger levels Encourage a sense of fullness Keep blood sugar in balance This helps create a calorie gap, which supports gradual and safe fat loss when paired with healthy habits and doctor oversight